These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 3756503)

  • 1. Behavioral effects of neurotensin in the open field: structure-activity studies.
    Elliott PJ; Chan J; Parker YM; Nemeroff CB
    Brain Res; 1986 Sep; 381(2):259-65. PubMed ID: 3756503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central neurotensin receptor activation produces differential behavioral responses in Fischer and Lewis rats.
    Bauco P; Rompré PP
    Psychopharmacology (Berl); 2003 Jul; 168(3):253-61. PubMed ID: 12682711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Motor hypoactivity induced by neurotensin and related peptides in mice.
    Meisenberg G; Simmons WH
    Pharmacol Biochem Behav; 1985 Feb; 22(2):189-93. PubMed ID: 3983212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential neurobehavioral effects of neurotensin and structural analogues.
    Jolicoeur FB; Barbeau A; Rioux F; Quirion R; St-Pierre S
    Peptides; 1981; 2(2):171-5. PubMed ID: 7291042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-antinociceptive activity studies with neurotensin.
    Furuta S; Kisara K; Sakurada S; Sakurada T; Sasaki Y; Suzuki K
    Br J Pharmacol; 1984 Sep; 83(1):43-8. PubMed ID: 6435708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of the neurotensin receptor 1 in the behavioral effects of two neurotensin agonists, NT-2 and NT69L: lack of hypothermic, antinociceptive and antipsychotic actions in receptor knockout mice.
    Mechanic JA; Sutton JE; Berson AE; Wu X; Kwan J; Schreiber R; Pang Z; Button DC
    Eur Neuropsychopharmacol; 2009 Jul; 19(7):466-75. PubMed ID: 19223157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of ICV administration of neurotensin and analogs on EEG in rats.
    Castel MN; Stutzmann JM; Lucas M; Lafforgue J; Blanchard JC
    Peptides; 1989; 10(1):95-101. PubMed ID: 2748429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of chronic infusion of neurotensin and a neurotensin NT1 selective analogue PD149163 on amphetamine-induced hyperlocomotion.
    Norman C; Beckett SR; Spicer CH; Ashton D; Langlois X; Bennett GW
    J Psychopharmacol; 2008 May; 22(3):300-7. PubMed ID: 18208905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blockade of nicotine-induced locomotor sensitization by a novel neurotensin analog in rats.
    Fredrickson P; Boules M; Yerbury S; Richelson E
    Eur J Pharmacol; 2003 Jan; 458(1-2):111-8. PubMed ID: 12498914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of neurotensin and neurotensin fragments on gastric acid secretion in man.
    Holst Pedersen J; Skov Olsen P; Kirkegaard P
    Regul Pept; 1986 Aug; 15(1):77-86. PubMed ID: 3763961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel neurotensin analog blocks cocaine- and D-amphetamine-induced hyperactivity.
    Boules M; Warrington L; Fauq A; McCormick D; Richelson E
    Eur J Pharmacol; 2001 Aug; 426(1-2):73-6. PubMed ID: 11525773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elective tolerance to behavioral effects of neurotensin.
    Rinkel GJ; Hoeke EC; van Wimersma Greidanus TB
    Physiol Behav; 1983 Oct; 31(4):467-70. PubMed ID: 6657768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Centrally administered [D-Trp11]neurotensin, as well as neurotensin protected from inactivation by thiorphan, modifies locomotion in rats in a biphasic manner.
    Nouel D; Dubuc I; Kitabgi P; Costentin J
    Peptides; 1990; 11(3):551-5. PubMed ID: 2381875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of a novel neurotensin peptide analog given extracranially on CNS behaviors mediated by apomorphine and haloperidol.
    Cusack B; Boules M; Tyler BM; Fauq A; McCormick DJ; Richelson E
    Brain Res; 2000 Feb; 856(1-2):48-54. PubMed ID: 10677610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-activity studies of neurotensin on muscular rigidity and tremors induced by 6-hydroxydopamine lesions in the posterolateral hypothalamus of the rat.
    Rivest R; St-Pierre S; Jolicoeur FB
    Neuropharmacology; 1991 Jan; 30(1):47-52. PubMed ID: 1904561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pupillary effects of neurotensin: structure-activity relationships.
    Hernandez DE; Simons KB; Spampinato D; Rioux F; St-Pierre S
    Neuropeptides; 1985 Dec; 6(6):561-8. PubMed ID: 2867486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A neurotensin analog, NT69L, attenuates intravenous nicotine self-administration in rats.
    Boules M; Oliveros A; Liang Y; Williams K; Shaw A; Robinson J; Fredrickson P; Richelson E
    Neuropeptides; 2011 Feb; 45(1):9-16. PubMed ID: 21047685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurotensin analogs [D-TYR11] and [D-PHE11]neurotensin resist degradation by brain peptidases in vitro and in vivo.
    Checler F; Vincent JP; Kitabgi P
    J Pharmacol Exp Ther; 1983 Dec; 227(3):743-8. PubMed ID: 6361231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of tolerance to the suppressant effect of the neurotensin analogue NT69L on amphetamine-induced hyperactivity.
    Hertel P; Byskov L; Didriksen M; Arnt J
    Eur J Pharmacol; 2001 Jun; 422(1-3):77-81. PubMed ID: 11430916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurotensin-induced polydipsia: a structure-activity study.
    Hawkins MF; Baker JD; Baumeister AA
    Brain Res; 1989 May; 487(1):188-91. PubMed ID: 2752285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.